1 Comment
⭠ Return to thread

The way I am handling this at the state level is preparing a presentation on what the state! will look like with and without action by the legislature to completely overall medical oversight. Without fundamental change in the way pharmas throw around money and the way we manage licensing of pharmaceuticals for use in the state, it appears most every significant pharma will move to mRNA technologies for delivery. There's two parts to the technology: the mRNA, or genetic part and the LNP part. (I feel people have to be careful with that term. Is the total package pre-primed so pieces of the RNA somehow make it back into the DNA?) Even if there is no genetic element (eg RNA), isn't the LNP part dangerous- too dangerous to use in a human or animal? If so, the legislation has to be so worded.

Expand full comment